Niconovum is a leading brand that offers innovative products to assist adults in quitting or reducing their tobacco consumption. Established in 2000 by Dr. Karl Olof Fagerström, a renowned expert on smoking cessation and nicotine dependence, Niconovum understands the need for effective Nicotine Replacement Therapy (NRT) options.

Their range of NRT products delivers nicotine efficiently and pleasantly, providing individuals with better alternatives to achieve their personal tobacco reduction goals. In 2009, Niconovum was acquired by Reynolds American Inc. (RAI), which was later acquired by British American Tobacco (BAT) in 2017.

BAT is committed to Building A Better Tomorrow™ by reducing the health impacts associated with its business. Niconovum sells their innovative NRT products under the Zonnic brand name in Sweden, Norway, Finland, and Iceland. Niconovum's Zonnic products are easy to use, offering fast and long-lasting relief from nicotine cravings.

They are 100% tobacco-free and come in various sizes and strengths to cater to personal preferences. All products are regulated medicines, approved by the necessary Medical Agencies, and are manufactured by audited and licensed medical manufacturers in Sweden and France. The Zonnic product range includes Zonnic Pouch, Zonnic Mouth Spray, and Zonnic Lozenge, which are regulated nicotine replacement therapies that effectively relieve nicotine cravings and withdrawal symptoms.

It is advisable to consult a doctor before using Zonnic if you are pregnant, breastfeeding, or have a serious heart condition. Detailed information can be found in the packaging leaflet. For individuals over 18 years of age, Niconovum provides Zonnic Quit Smoking Guides to learn more about NRT products and the quitting process.

If you have any questions or want more information about their products, feel free to contact Niconovum. Rest assured, they prioritize the confidentiality and protection of individuals' shared information in accordance with General Data Protection Regulations